Now Cactus Life Sciences Companies, nspm and eluSCIdate

Cactus Life Sciences Announces the Acquisition of nspm and eluSCIdate

FOR IMMEDIATE RELEASE Princeton, NJ, April 24, 2024 - Cactus Life Sciences, a leading global scientific communications agency that works with blue chip pharma and biotechnology companies, announced today that they have acquired nspm and eluSCIdate, two dynamic medical communications and publications companies headquartered in Meggen, Switzerland with an office in the UK. Cactus Life…...
Read More

Top Stories

Target, Bull's Eye, Omnichannel Strategy, Success, Efficiency

Optimizing Medical Affairs with Modular Content:

Turn your organization into an “efficiency powerhouse” with...
Pencil writing concise, complete, clear plain language communication

Speak Clearly: Challenges and Strategies for

Medical Affairs professionals play a crucial role in...
Omnichannel

The Quest for Omnichannel: Is Medical Affairs

Commercial and Medical Affairs must partner with each other...
Target, Bull's Eye, Omnichannel Strategy, Success, Efficiency

Optimizing Medical Affairs with Modular Content: A Journey through Every Step and Stage of Omnichannel Excellence

Turn your organization into an “efficiency powerhouse” with the transformative power of modular content and...

Maximizing Efficiency and Compliance with Expert Compendia and Monograph Review Services

Cactus Life Sciences specializes in compendia reviews, providing invaluable assistance to pharmaceutical companies. Our expert...
Digital Publication Extenders, Digital Icons, Digital Publications

Digital Publication Extenders: Creating an Ecosystem for a More Engaging and Informative Experience

While creating digital publication extenders may seem complex, Cactus Life Sciences can assist in developing...
Medical Review

Uncovering the Benefits of Medical Review: A Comprehensive Overview

Medical review promises scientific data accuracy and has paramount importance at all the stages of...
Periodic Safety Update Report (PSUR) - Medical Device

Periodic Safety Update Report (PSUR): A Breakdown of MDCG 2022-21

A well-structured, clear, and concise PSUR enables a seamless notified body review. Read our key...

Launch Excellence: The Path Forward for Medical Affairs

Learn how Medical Affairs can redefine launch excellence by streamlining the journey from clinical trial...

Learn more ABOUT our company.